Journal of Biological Chemistry · 2006 · 212 citations · 33 references
Life SciencesCell BiologyPharmacologyCell SignalingMolecular PharmacologySignal TransductionCardiac PhysiologyIon Channel PharmacologyIon Channel PhysiologyIon Channel SignalingMitochondrial PhysiologyMitochondrial SignalingGuanylyl Cyclase IsoformsGuanylyl Cyclase RegulationMitochondrial Cell Death PathwaysMitochondrial Permeability Transition Pore SignalingNitric Oxide Synthase RegulationPotassium Channel OpenersProtein Kinase G SignalingReactive Oxygen Species Generation
Myocardial infarction is a manifestation of necrotic cell death as a result of opening of the mitochondrial permeability transition (MPT). Receptor-mediated cardioprotection is triggered by an intracellular signaling pathway that includes phosphatidylinositol 3-kinase, endothelial nitric-oxide synthase, guanylyl cyclase, protein kinase G (PKG), and the mitochondrial KATP channel (mitoKATP). In this study, we explored the pathway that links mitoKATP with the MPT. We confirmed previous findings that diazoxide and activators of PKG or protein kinase C (PKC) inhibited MPT opening. We extended these results and showed that other K+ channel openers as well as the K+ ionophore valinomycin also inhibited MPT opening and that this inhibition required reactive oxygen species. By using isoform-specific peptides, we found that the effects of KATP channel openers, PKG, or valinomycin were mediated by a PKCϵ. Activation of PKCϵ by phorbol 12-myristate 13-acetate or H2O2 resulted in mitoKATP-independent inhibition of MPT opening, whereas activation of PKCϵ by PKG or the specific PKCϵ agonist ψϵ receptor for activated C kinase caused mitoKATP-dependent inhibition of MPT opening. Exogenous H2O2 inhibited MPT, because of its activation of PKCϵ, with an IC50 of 0.4 (±0.1) μm. On the basis of these results, we propose that two different PKCϵ pools regulate this signaling pathway, one in association with mitoKATP and the other in association with MPT. Myocardial infarction is a manifestation of necrotic cell death as a result of opening of the mitochondrial permeability transition (MPT). Receptor-mediated cardioprotection is triggered by an intracellular signaling pathway that includes phosphatidylinositol 3-kinase, endothelial nitric-oxide synthase, guanylyl cyclase, protein kinase G (PKG), and the mitochondrial KATP channel (mitoKATP). In this study, we explored the pathway that links mitoKATP with the MPT. We confirmed previous findings that diazoxide and activators of PKG or protein kinase C (PKC) inhibited MPT opening. We extended these results and showed that other K+ channel openers as well as the K+ ionophore valinomycin also inhibited MPT opening and that this inhibition required reactive oxygen species. By using isoform-specific peptides, we found that the effects of KATP channel openers, PKG, or valinomycin were mediated by a PKCϵ. Activation of PKCϵ by phorbol 12-myristate 13-acetate or H2O2 resulted in mitoKATP-independent inhibition of MPT opening, whereas activation of PKCϵ by PKG or the specific PKCϵ agonist ψϵ receptor for activated C kinase caused mitoKATP-dependent inhibition of MPT opening. Exogenous H2O2 inhibited MPT, because of its activation of PKCϵ, with an IC50 of 0.4 (±0.1) μm. On the basis of these results, we propose that two different PKCϵ pools regulate this signaling pathway, one in association with mitoKATP and the other in association with MPT. A major component of ischemia-reperfusion injury is necrotic cell death, manifested at the organ level as infarction. Necrotic cell death is widely thought to be the consequence of opening the mitochondrial permeability transition (MPT), 2The abbreviations used are: MPT, mitochondrial permeability transition; mitoKATP, the mitochondrial ATP-sensitive K+ channel; CCCP, carbonyl cyanide m-chlorophenylhydrazone; TEA+, tetraethylammonium cation; 5-HD, 5-hydroxydecanoic acid; PMA, 12-phorbol 13-myristate acetate; PKC, protein kinase C; PKG, protein kinase G isoform 1α; TPP+, tetraphenylphosphonium ion; ROS, reactive oxygen species; RACK, receptor for activated C kinase; RR, ruthenium red; Dzx, diazoxide; MPG, N-2-mercaptopropionylglycine. 2The abbreviations used are: MPT, mitochondrial permeability transition; mitoKATP, the mitochondrial ATP-sensitive K+ channel; CCCP, carbonyl cyanide m-chlorophenylhydrazone; TEA+, tetraethylammonium cation; 5-HD, 5-hydroxydecanoic acid; PMA, 12-phorbol 13-myristate acetate; PKC, protein kinase C; PKG, protein kinase G isoform 1α; TPP+, tetraphenylphosphonium ion; ROS, reactive oxygen species; RACK, receptor for activated C kinase; RR, ruthenium red; Dzx, diazoxide; MPG, N-2-mercaptopropionylglycine. as proposed originally by Crompton et al. (1Crompton M. Ellinger H. Costi A. Biochem. J. 1988; 255: 357-360PubMed Google Scholar) and recently by Di Lisa et al. (2Di Lisa F. Menabo R. Canton M. Barile M. Bernardi P. J. Biol. Chem. 2001; 276: 2571-2575Abstract Full Text Full Text PDF PubMed Scopus (558) Google Scholar). Strong protection against ischemia-reperfusion injury is afforded by a brief preliminary ischemic period, a phenomenon known as ischemic preconditioning, which was also shown to reduce MPT opening (3Hausenloy D.J. Maddock H.L. Baxter G.F. Yellon D.M. Cardiovasc. Res. 2002; 55: 534-543Crossref PubMed Scopus (480) Google Scholar, 4Hausenloy D.J. Tsang A. Yellon D.M. Trends Cardiovasc. Med. 2005; 15: 69-75Crossref PubMed Scopus (379) Google Scholar). However, it is unclear how MPT opening is prevented when cardioprotection is triggered by ischemic preconditioning or pharmacological mitoKATP openers such as diazoxide. In this regard, Korge et al. (5Korge P. Honda H.M. Weiss J.N. Proc. Natl. Acad. Sci. U. S. A. 2002; 99: 3312-3317Crossref PubMed Scopus (159) Google Scholar) have made important progress. They simulated ischemia in isolated mitochondria with anoxia and then exposed them to elevated Ca2+ and phosphate (Pi). These conditions caused MPT opening and cytochrome c loss, which were blocked by diazoxide or phorbol 12-myristate 13-acetate (PMA). Both effects were negated by 5-hydroxydecanoate (5-HD), indicating that the protective effect of PKC in blocking MPT pore opening operates through mitoKATP opening. Kim et al. (6Kim J.S. Ohshima S. Pediaditakis P. Lemasters J.J. Hepatology. 2004; 39: 1533-1543Crossref PubMed Scopus (98) Google Scholar) showed that MPT was inhibited by cyclic GMP in the presence of a cytosolic extract, implicating a guanylyl cyclase-dependent signaling pathway. Baines et al. (7Baines C.P. Song C.X. Zheng Y.T. Wang G.W. Zhang J. Wang O.L. Guo Y. Bolli R. Cardwell E.M. Ping P. Circ. Res. 2003; 92: 873-880Crossref PubMed Scopus (398) Google Scholar) showed that mice with cardiac-specific expression of recombinant PKCϵ showed inhibition of MPT opening in heart mitochondria and identified a multiprotein complex in mitochondria containing PKCϵ, adenine nucleotide translocator, the voltage-dependent anion channel, and hexokinase. Adenine nucleotide translocator, voltage-dependent anion channel, hexokinase, and cyclophilin D are hypothesized to be constituents of MPT (8Crompton M. J. Physiol. (Lond.). 2000; 529: 11-21Crossref Scopus (276) Google Scholar). These findings take on greater significance with our recent demonstration that protein kinase G (PKG) opens mitoKATP and that this effect is mediated via an endogenous mitochondrial PKCϵ (9Costa A.D. Garlid K.D. West I.C. Lincoln T.M. Downey J.M. Cohen M.V. Critz S.D. Circ. Res. 2005; 97: 329-336Crossref PubMed Scopus (240) Google Scholar). We showed that addition of PKG + cGMP to isolated mitochondria from rat heart, brain, or liver resulted in increased K+ influx comparable with that induced by diazoxide or cromakalin and that these effects were blocked by PKCϵ-specific inhibitors. We now show that exogenous PKG + cGMP inhibits MPT and that this protective effect is blocked by inhibitors of PKG, PKCϵ, and mitoKATP. Thus, mitoKATP is an obligatory intermediate in the PKG-dependent inhibition of MPT. We show that valinomycin mimics the effects of PKG, PKCϵ, or mitoKATP activators, establishing that this protective effect of mitoKATP opening is due specifically to K+ influx into the mitochondrion. Moreover, inhibition of MPT by mitoKATP opening or valinomycin is blocked by an ROS scavenger and by PKCϵ inhibitors, indicating that a mitoKATP-dependent increase in mitochondrial ROS production is the signal transmitted to the PKCϵ-MPT interaction. Activation of endogenous PKCϵ by PMA or H2O2 also inhibits MPT opening, and this effect does not involve mitoKATP opening. The latter results suggest that two different PKCϵ-containing subcomplexes modify these mitochondrial functions. These and other recent findings from our group lead to a preliminary model of the mitochondrial segment of the cardioprotective signaling pathway that inhibits MPT opening and cell necrosis. Mitochondrial Isolation—Heart, liver, and brain mitochondria were isolated by differential centrifugation from male Sprague-Dawley rats (220–240 g) exactly as described previously (9Costa A.D. Garlid K.D. West I.C. Lincoln T.M. Downey J.M. Cohen M.V. Critz S.D. Circ. Res. 2005; 97: 329-336Crossref PubMed Scopus (240) Google Scholar). Mitoplasts were prepared by digitonin permeabilization of the outer membrane (10Schnaitman C. Greenawalt J.W. J. Cell Biol. 1968; 38: 158-175Crossref PubMed Scopus (1010) Google Scholar). Measurement of Light Scattering—Matrix swelling is the standard technique for assaying the MPT. As described previously (11Beavis A.D. Brannan R.D. Garlid K.D. J. Biol. Chem. 1985; 260: 13424-13433Abstract Full Text PDF PubMed Google Scholar, 12Garlid K.D. Beavis A.D. J. Biol. Chem. 1985; 260: 13434-13441Abstract Full Text PDF PubMed Google of mitochondrial were at and and are as which is for protein as shown in of of were by the of a of the the MPT by the mitochondrial in this are in as swelling which is by swelling in the and the presence of A as and significance of the of the was using A of was and is in by an of that with K+ of and phosphate tetraethylammonium or K+ were also with and In of were of and of of MPT have in containing to and and which MPT P. Physiol. PubMed Scopus Google Scholar). However, in to mitoKATP, PKC, and MPT, it was to containing and By using these we that caused a MPT opening a of Bernardi and C. S. R. Bernardi P. J. Biol. Chem. Full Text PDF PubMed Google Scholar) found that the is a the of mitochondria that have at a and showed that it is to MPT opening by of ruthenium and was in of the of mitochondrial were to at was at to Ca2+ was at and to was at Ca2+ were using the Biochem. PubMed Scopus Google Scholar). of from and made from mitochondria were using Biochem. PubMed Scopus Google with and on The were blocking with in were exposed to in a by A was used to the kinase G isoform and were from PKC isoform-specific were by to the H. Guo Y. Bolli R. G.W. Proc. Natl. Acad. Sci. U. S. A. 2001; PubMed Scopus Google Scholar). other were from The and used in this was comparable with that used in our previous and the in A.D. Garlid K.D. West I.C. Lincoln T.M. Downey J.M. Cohen M.V. Critz S.D. Circ. Res. 2005; 97: 329-336Crossref PubMed Scopus (240) Google and In the the a specific of is the of required to of phosphate from to the at We used to PKG in is and in (9Costa A.D. Garlid K.D. West I.C. Lincoln T.M. Downey J.M. Cohen M.V. Critz S.D. Circ. Res. 2005; 97: 329-336Crossref PubMed Scopus (240) Google Scholar). of MPT by of in K+ and is shown in the swelling is because of MPT opening is confirmed by the that it was inhibited by A. The KATP channel diazoxide also inhibited MPT opening, and + blocked this In this and the that we mitoKATP openers and or the mitochondria and the results of as in be that and and mitoKATP channel openers inhibited MPT opening and that this inhibition was blocked by the mitoKATP M. P. Garlid K.D. J. Biol. Chem. Full Text Full Text PDF PubMed Google Scholar) as well as by the mitoKATP tetraphenylphosphonium P. Garlid K.D. J. Biol. Chem. 2004; Full Text Full Text PDF PubMed Scopus Google Scholar). valinomycin also inhibited MPT opening at a that K+ to the as a KATP channel C. A. West I.C. Garlid K.D. J. Physiol. PubMed Scopus Google Scholar). As this effect of valinomycin was not blocked by We from these results that mitoKATP opening inhibits MPT in isolated heart mitochondria and that the inhibition is a consequence of mitoKATP-dependent K+ mitoKATP MPT via ROS Activation of results the does increased K+ into the inhibition of We have shown that K+ influx to and to increased ROS production C. A. West I.C. Garlid K.D. J. Physiol. PubMed Scopus Google Scholar, K.D. Res. 2000; PubMed Scopus Google Scholar, A. Garlid K.D. J. Cell 2005; 38: Scholar). is known that increased ROS protein R. U. J. Biol. Chem. 2002; Full Text Full Text PDF PubMed Scopus Google and it that PKCϵ inhibits MPT opening in heart mitochondria (5Korge P. Honda H.M. Weiss J.N. Proc. Natl. Acad. Sci. U. S. A. 2002; 99: 3312-3317Crossref PubMed Scopus (159) Google Scholar, C.P. Song C.X. Zheng Y.T. Wang G.W. Zhang J. Wang O.L. Guo Y. Bolli R. Cardwell E.M. Ping P. Circ. Res. 2003; 92: 873-880Crossref PubMed Scopus (398) Google Scholar). we hypothesized that a PKC be an intermediate in this We the effects of ROS and PKC inhibitors on MPT with the results shown in These show that inhibition of MPT opening was blocked by the scavenger MPG, by the PKC inhibitors and and by the PKCϵ-specific H. Guo Y. Bolli R. G.W. Proc. Natl. Acad. Sci. U. S. A. 2001; PubMed Scopus Google Scholar). Moreover, MPT inhibition mediated by valinomycin was also inhibited by or MPT inhibition by diazoxide was not blocked by the by the or by the of On the basis of these we that mitoKATP opening inhibits MPT via PKCϵ which is activated by or mitoKATP-dependent ROS MPT via mitoKATP, ROS, and showed recently that addition of PKG + cGMP to isolated rat heart mitochondria opening of mitoKATP (9Costa A.D. Garlid K.D. West I.C. Lincoln T.M. Downey J.M. Cohen M.V. Critz S.D. Circ. Res. 2005; 97: 329-336Crossref PubMed Scopus (240) Google Scholar). with the results in and that PKG + cGMP MPT in a and is the as shown in of MPT by PKG + cGMP was blocked by the by the mitoKATP 5-HD, and TPP+, by the ROS scavenger MPG, and by the PKCϵ inhibitors and MPT inhibition was not blocked by the Moreover, PKG PKG in the of cGMP effect on MPT not these we that PKG inhibits MPT via mitoKATP opening and that this effect is mediated by PKCϵ and for and the of in that the mitoKATP inhibition of MPT to that PKCϵ is of the that PKCϵ is required for mitoKATP opening by PKG + cGMP (9Costa A.D. Garlid K.D. West I.C. Lincoln T.M. Downey J.M. Cohen M.V. Critz S.D. Circ. Res. 2005; 97: 329-336Crossref PubMed Scopus (240) Google Scholar) that PKCϵ is of mitoKATP. that the of how PKCϵ be and of mitoKATP. In and we that MPT was inhibited by the PKCϵ activators PMA and MPT was not inhibited by the not by PMA and H2O2 was prevented by the PKCϵ-specific not by A and or not Thus, PKCϵ activation by PMA or H2O2 MPT of mitoKATP. is by the that PMA and H2O2 have effects in K+ and in that the is to PMA or H2O2 inhibition of MPT in that a PKCϵ that MPT the of mitoKATP. The in are in with the findings of Korge et al. (5Korge P. Honda H.M. Weiss J.N. Proc. Natl. Acad. Sci. U. S. A. 2002; 99: 3312-3317Crossref PubMed Scopus (159) Google found that blocked PMA protection as it diazoxide A for this result is that mitoKATP was not blocked addition of PMA, and MPT was blocked via the mitoKATP-dependent pathway. We the result we PMA with In our PMA was these not to the protective effect of PMA or as shown in this of PMA or H2O2 to MPT by a mitoKATP-independent pathway is confirmed by the findings in In to the results with PMA or PKCϵ activation by PKG + cGMP (9Costa A.D. Garlid K.D. West I.C. Lincoln T.M. Downey J.M. Cohen M.V. Critz S.D. Circ. Res. 2005; 97: 329-336Crossref PubMed Scopus (240) Google Scholar) or by the MPT and mitoKATP opening as an is by the that the effects of these were by or for in opening mitoKATP was and was also in blocking MPT in the presence of These findings suggest that two different PKCϵ pools are in this of the mitochondrial signaling pathway, one in association with mitoKATP and the other in association with MPT. is confirmed by in in which or PKG + or was in MPT. of MPT in is thought to be an ROS, and the in heart 2001; PubMed Scopus Google Scholar, F. Biol. Med. 2002; PubMed Scopus Google Scholar). In the presence of MPT be with of Ca2+ and the of H2O2 that are by the In the two of Ca2+ caused MPT when H2O2 was to the MPT opening was MPT also be induced by a of Ca2+ and H2O2 2001; PubMed Scopus Google Scholar). that Ca2+ was to MPT, whereas Ca2+ H2O2 caused MPT opening. with a of H2O2 inhibited the of MPT. The protection afforded by preconditioning of H2O2 is mediated by activation of the PKCϵ, as shown by of the inhibition by the specific this protection is of mitoKATP as by the of to it In not we have the of H2O2 inhibition of MPT and found that the IC50 is mitoKATP-dependent of MPT via ROS and PKCϵ in and pathway that the signal from PKG to mitoKATP is also in rat brain and rat liver mitochondria (9Costa A.D. Garlid K.D. West I.C. Lincoln T.M. Downey J.M. Cohen M.V. Critz S.D. Circ. Res. 2005; 97: 329-336Crossref PubMed Scopus (240) Google Scholar). The in show that the in rat liver mitochondria are exactly the as described for rat heart mitochondria in in with for we in isolated rat brain mitochondria this signaling pathway to be a phenomenon in of PKCϵ in and heart mitochondria and were by and to for with and Biochem. PubMed Scopus Google Scholar). As shown in of PKC were in mitochondrial and whereas a was found in with and Biochem. PubMed Scopus Google Scholar). we that heart mitochondria endogenous PKCϵ. The that PKCϵ is in that this PKCϵ is with the outer of the membrane or in the or In the of mitoKATP opening to be as protective and MPT opening as The these two have previously of the Korge et al. (5Korge P. Honda H.M. Weiss J.N. Proc. Natl. Acad. Sci. U. S. A. 2002; 99: 3312-3317Crossref PubMed Scopus (159) Google Scholar) have shown that activation of mitoKATP results in inhibition of MPT. Korge et al. (5Korge P. Honda H.M. Weiss J.N. Proc. Natl. Acad. Sci. U. S. A. 2002; 99: 3312-3317Crossref PubMed Scopus (159) Google Scholar) and also Baines et al. (7Baines C.P. Song C.X. Zheng Y.T. Wang G.W. Zhang J. Wang O.L. Guo Y. Bolli R. Cardwell E.M. Ping P. Circ. Res. 2003; 92: 873-880Crossref PubMed Scopus (398) Google Scholar) have shown that PKC activation is to MPT. Kim et al. (6Kim J.S. Ohshima S. Pediaditakis P. Lemasters J.J. Hepatology. 2004; 39: 1533-1543Crossref PubMed Scopus (98) Google Scholar) have shown that activation of a cytosolic PKG resulted in inhibition of MPT. In of our recent results that PKG opens mitoKATP via PKCϵ (9Costa A.D. Garlid K.D. West I.C. Lincoln T.M. Downey J.M. Cohen M.V. Critz S.D. Circ. Res. 2005; 97: 329-336Crossref PubMed Scopus (240) Google Scholar) and that mitoKATP activation ROS production A. Garlid K.D. J. Cell 2005; 38: we now propose a of a signaling pathway in mitochondria that the The in this show that mitoKATP opening inhibits MPT opening in heart, liver, and brain mitochondria and that it does via K+ increased ROS, and PKCϵ We and the findings of Korge et al. (5Korge P. Honda H.M. Weiss J.N. Proc. Natl. Acad. Sci. U. S. A. 2002; 99: 3312-3317Crossref PubMed Scopus (159) Google Scholar) and Baines et al. (7Baines C.P. Song C.X. Zheng Y.T. Wang G.W. Zhang J. Wang O.L. Guo Y. Bolli R. Cardwell E.M. Ping P. Circ. Res. 2003; 92: 873-880Crossref PubMed Scopus (398) Google Scholar) that PKCϵ is in mitochondria The complex of is in which also the and on which the is a of the mitoKATP, PKCϵ, and MPT. that two different PKCϵ pools are is of mitoKATP and is required for opening of mitoKATP by PKG + cGMP A.D. Garlid K.D. West I.C. Lincoln T.M. Downey J.M. Cohen M.V. Critz S.D. Circ. Res. 2005; 97: 329-336Crossref PubMed Scopus (240) Google and the in and is of mitoKATP and is required for inhibition of MPT and and the in and The of the the basis of these and the proposed cardioprotective signaling pathway in In activated PKG, which the outer mitochondrial a protein at the of the outer by an to activation of which is to the outer of the mitochondrial In mitoKATP, it to and K+ influx (9Costa A.D. Garlid K.D. West I.C. Lincoln T.M. Downey J.M. Cohen M.V. Critz S.D. Circ. Res. 2005; 97: 329-336Crossref PubMed Scopus (240) Google Scholar). to C. A. West I.C. Garlid K.D. J. Physiol. PubMed Scopus Google which a increase in H2O2 and A. Garlid K.D. J. Cell 2005; 38: Scholar). H2O2 inhibition of MPT opening We have found that increased H2O2 also mitoKATP opening and a this is not is it is that H2O2 as a in cell signaling by a of R. R. 99: PubMed Scopus Google Y. Acad. Sci. 2003; PubMed Scopus Google of Mitochondrial show that PMA, and inhibition of MPT opening and that this inhibition is prevented by not by the have for mitoKATP opening (9Costa A.D. Garlid K.D. West I.C. Lincoln T.M. Downey J.M. Cohen M.V. Critz S.D. Circ. Res. 2005; 97: 329-336Crossref PubMed Scopus (240) Google Scholar). and we that PKCϵ the of the of mitoKATP and MPT. the outer membrane a to the we that these are endogenous to These results by Baines et al. (7Baines C.P. Song C.X. Zheng Y.T. Wang G.W. Zhang J. Wang O.L. Guo Y. Bolli R. Cardwell E.M. Ping P. Circ. Res. 2003; 92: 873-880Crossref PubMed Scopus (398) Google inhibition of MPT when heart mitochondria were with exogenous PKCϵ. These also PMA in the as shown in mitoKATP and MPT PKC is to complex In the presence of an such as or or PMA is thought to the by at the of the from the A. PubMed Google Scholar). ROS PKCϵ by to and the of J. Biol. Chem. 2000; Full Text Full Text PDF PubMed Scopus Google Scholar). et al. R. U. J. Biol. Chem. 2002; Full Text Full Text PDF PubMed Scopus Google Scholar) that is to two in PKC and that to one or of the other to and PKC activation also be with to a it is to a specific J. J. Biol. Chem. 2004; Full Text Full Text PDF PubMed Scopus Google Scholar). and 2001; PubMed Scopus Google Scholar, 2002; PubMed Scopus Google Scholar, R. 2005; PubMed Scopus Google Scholar) have identified and and hypothesized specific and to We have used a specific of PKCϵ and a specific of PKCϵ and kinase 2001; PubMed Scopus Google Scholar). These were to with specific of PKCϵ and Thus, the as an agonist by PKCϵ, and the to the 2002; PubMed Scopus Google Scholar, R. 2005; PubMed Scopus Google Scholar). The of show for the that H2O2 inhibits MPT and that it does via activation of PKCϵ and H2O2 shown to be a signaling R. R. 99: PubMed Scopus Google Scholar, C. J. Biol. Chem. Full Text Full Text PDF PubMed Scopus Google Scholar, J. A. J. Biol. Chem. Full Text Full Text PDF PubMed Scopus Google Scholar, M. Biochem. PubMed Scopus Google Scholar, H. P. J. Physiol. 2002; Scopus Google Scholar, Y. Acad. Sci. 2003; PubMed Scopus Google its with MPT previously that of an an of MPT opening 2001; PubMed Scopus Google Scholar, F. Biol. Med. 2002; PubMed Scopus Google Scholar, H.M. Korge P. Weiss J.N. Y. Acad. Sci. 2005; PubMed Scopus Google Scholar). The important of H2O2 to from its we show H2O2 as a signaling against MPT pore opening in isolated at a at that shown to MPT pore opening The demonstration that to a of H2O2 against MPT opening caused by of H2O2 be of for were shown to be from simulated ischemia via a H2O2 of a pathway that PKCϵ and mitoKATP H. P. J. Physiol. 2002; Scopus Google Scholar). for Mitochondrial in cardioprotection R. F. 2005; PubMed Scopus Google Scholar, C. M. S. C. Physiol. 2004; PubMed Scopus Google Scholar, C.P. Zhang J. Wang Zheng Cardwell E.M. Bolli R. Ping P. Circ. Res. 2002; PubMed Scopus Google and it is known that signaling by this PKCϵ on its T.M. Ping P. J. 2003; Full Text Full Text PDF PubMed Scopus Google Scholar, Biochem. J. 2003; PubMed Scopus Google Scholar, Biochem. J. 2004; PubMed Scopus Google Scholar, P. Circ. Res. 2003; PubMed Scopus Google Scholar). In the model of is with and mitoKATP, whereas is with and MPT. The that two are is by the Activation of PKCϵ by PMA or H2O2 opens mitoKATP and inhibits MPT. of these whereas and mitoKATP opening and have effect on MPT inhibition by PMA or H2O2 that MPT the of mitoKATP The demonstration that PMA or H2O2 inhibits MPT in the of mitoKATP that of mitoKATP. PKG inhibition of MPT mitoKATP opening A and it is known that PKG opens mitoKATP by a mitochondrial PKCϵ (9Costa A.D. Garlid K.D. West I.C. Lincoln T.M. Downey J.M. Cohen M.V. Critz S.D. Circ. Res. 2005; 97: 329-336Crossref PubMed Scopus (240) Google it that this PKC MPT were one PKCϵ in this pathway, PKG be to MPT of mitoKATP. These findings are with the of Ping P. Circ. Res. 2003; PubMed Scopus Google Scholar) that PKCϵ does not in with a of other of on the proposed by which PKCϵ J. J. Biol. Chem. 2004; Full Text Full Text PDF PubMed Scopus Google Scholar, 2001; PubMed Scopus Google are to to this in the to the then is to not A is on the of the two as the of the is whereas is it is that the membrane and with a PKCϵ on its whereas it is for to the membrane in the of a membrane Thus, the findings are with the that is on the of the whereas is on the of the The of this mitoKATP on Ca2+ cardioprotective effect of mitoKATP opening shown to be of the of MPT D.J. Yellon D.M. S. J. Physiol. 2004; PubMed Scopus Google Scholar). The effect of mitoKATP on MPT to Ca2+ from the induced by K+ into mitochondria M. M. Circ. Res. 2001; PubMed Scopus Google Scholar, H. Y. C. H. H. 2004; PubMed Scopus Google Scholar, J. 2005; PubMed Scopus Google Scholar). However, this and the results of such have due to the different conditions the conditions in which we isolated we showed that pharmacological of diazoxide induced opening of mitoKATP Ca2+ or membrane C. A. West I.C. Garlid K.D. J. Physiol. PubMed Scopus Google Scholar, S. P. Garlid K.D. J. Physiol. 2001; Scholar). the results shown be to Ca2+ into the mitochondrial show that mitoKATP opening, by intracellular signaling (9Costa A.D. Garlid K.D. West I.C. Lincoln T.M. Downey J.M. Cohen M.V. Critz S.D. Circ. Res. 2005; 97: 329-336Crossref PubMed Scopus (240) Google Scholar) or by KATP channel openers, inhibition of MPT opening. be an in manifestation of a cardioprotective because MPT opening is to be the of necrotic cell death (1Crompton M. Ellinger H. Costi A. Biochem. J. 1988; 255: 357-360PubMed Google Scholar, Lisa F. Menabo R. Canton M. Barile M. Bernardi P. J. Biol. Chem. 2001; 276: 2571-2575Abstract Full Text Full Text PDF PubMed Scopus (558) Google Scholar). of PKCϵ these was from the of a of and that are specific for PKCϵ. of these is the of two pools of the that the PKC isoform effects at in the cytosolic and mitochondrial
33
Fabio Di Lisa, Roberta Menabò, Marcella Canton et al. · Journal of Biological Chemistry · 2001 · 679 citations · Full text